CIK 0001055726 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue (USD) | 65343 | 832010 | 10.3 M | |
| Net income (USD) | -279.8 M | -166.4 M | ||
| Diluted EPS (USD/shares) | -1.81 | -6.09 | -14.07 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-06 | 8-K | 8-K items 5.03,9.01 | 2026-10-06 |
| 2026-08-12 | 8-K | 8-K items 2.02,9.01 | 2026-08-12 |
| 2026-08-12 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-12 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-07 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-06 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-31 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-07-31 | 8-K | 8-K items 1.01,8.01,9.01 | 2026-07-29 |
| 2026-07-30 | 424B5 | 424B5 | |
| 2026-07-29 | 8-K | 8-K items 2.02 | 2026-07-29 |
| 2026-07-29 | 424B5 | 424B5 | |
| 2026-07-10 | EFFECT | EFFECT items ,, | |
| 2026-07-02 | S-3 | S-3 | |
| 2026-05-26 | S-8 | S-8 | |
| 2026-05-21 | 4 | FORM 4 | 2026-05-20 |
| 2026-05-21 | 4 | FORM 4 | 2026-05-20 |
| 2026-05-21 | 4 | FORM 4 | 2026-05-20 |
| 2026-05-21 | 4 | FORM 4 | 2026-05-20 |
| 2026-05-21 | 4 | FORM 4 | 2026-05-20 |
| 2026-05-21 | 4 | FORM 4 | 2026-05-20 |
| 2026-05-21 | 4 | FORM 4 | 2026-05-20 |
| 2026-05-21 | 4 | FORM 4 | 2026-05-20 |
| 2026-05-21 | 4 | FORM 4 | 2026-05-20 |
| 2026-05-21 | 4 | FORM 4 | 2026-05-20 |
| 2026-05-21 | 4 | FORM 4 | 2026-05-20 |
Forms on file (last 1,000): 4 476, 8-K 161, 10-Q 56, 424B5 37, SC 13G/A 29, 3 27, S-8 20, DEF 14A 20. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=INO (0.002 USD), /gw/filings/filings?ticker=INO&form=8-K, /gw/filings/facts?ticker=INO&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange